Chemical activators of Olr72 can initiate a cascade of intracellular signaling events that lead to the protein's functional activation. Forskolin, a plant-derived compound, directly stimulates adenylate cyclase, which boosts the levels of cAMP within the cell. This surge in cAMP triggers protein kinase A (PKA) to phosphorylate Olr72, catalyzing its activation. Similar adenylate cyclase activation and subsequent Olr72 activation can be achieved through several adrenergic agonists. Isoproterenol, a synthetic compound, binds to beta-adrenergic receptors, and Epinephrine, an endogenous hormone, interacts with both alpha and beta-adrenergic receptors. Both of these lead to the activation of adenylate cyclase, thereby enhancing cAMP production, which in turn activates PKA and promotes the phosphorylation and activation of Olr72.
Additionally, Histamine, which targets H2 receptors, and Serotonin, engaging with 5-HT receptors, can also elevate adenylate cyclase activity. This increase in enzyme activity augments cAMP levels, leading to PKA-mediated phosphorylation and consequent activation of Olr72. Dopamine and Adenosine further contribute to the activation of Olr72 by binding to their respective D1-like and A2 receptors, which are positively coupled to adenylate cyclase, thus elevating cAMP and activating PKA that phosphorylates Olr72. Prostaglandin E2 and Glucagon, through their respective receptors EP2/EP4 and the glucagon receptor, also activate adenylate cyclase, enhancing cAMP, activating PKA, and leading to the phosphorylation and activation of Olr72. Caffeine and IBMX, both phosphodiesterase inhibitors, prevent the breakdown of cAMP, maintaining PKA activity for a longer duration, which supports the phosphorylation and activation of Olr72. Lastly, BAY 60-6583 selectively activates adenosine A2B receptors, leading to a rise in adenylate cyclase activity and cAMP levels, which culminates in the PKA-mediated phosphorylation and activation of Olr72. Each of these chemicals, by influencing specific signaling pathways, ensures the activation of Olr72 through distinct yet convergent mechanisms that center around the modulation of cAMP levels and PKA activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol binds to beta-adrenergic receptors, which leads to adenylate cyclase activation. This causes an increase in cAMP levels, activating PKA and subsequent phosphorylation of Olr72. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages alpha and beta-adrenergic receptors, stimulating adenylate cyclase and increasing cAMP. This leads to PKA activation and phosphorylation of Olr72. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine interacts with H2 receptors, increasing adenylate cyclase activity. The increased cAMP levels result in PKA activation and the phosphorylation and activation of Olr72. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Serotonin acts on 5-HT receptors that are coupled to adenylate cyclase, increasing cAMP and activating PKA, which phosphorylates and activates Olr72. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine binds to D1-like receptors, activating adenylate cyclase. The subsequent rise in cAMP activates PKA, leading to Olr72 activation through phosphorylation. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine interacts with A2 receptors, stimulating adenylate cyclase, increasing cAMP, and activating PKA, which phosphorylates and activates Olr72. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 engages EP2/EP4 receptors, leading to adenylate cyclase activation. Increase in cAMP activates PKA, which leads to Olr72 activation through phosphorylation. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine inhibits phosphodiesterases, preventing cAMP breakdown, which sustains PKA activity for phosphorylation and activation of Olr72. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a non-specific phosphodiesterase inhibitor, increases cAMP levels by preventing its degradation, leading to PKA activation and Olr72 phosphorylation. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
BAY 60-6583 selectively activates adenosine A2B receptors, leading to increased adenylate cyclase activity, raised cAMP levels, and PKA-mediated phosphorylation and activation of Olr72. | ||||||